Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2012-06-28

Clinical Trial Update: Evaluation of Phenotypic and Genetic Properties in Male Subjects Affected by Hypohidrotic Ectodermal Dysplasia - A

View source ↗

Summary

A completed Edimer Pharmaceuticals study evaluating phenotypic and genetic characteristics in male participants with Hypohidrotic Ectodermal Dysplasia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Edimer Pharmaceuticals | Conditions: Hypohidrotic Ectodermal Dysplasia | Status: COMPLETED